• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ELECSYS RUBELLA IGG IMMUNOASSAY; ENZYME LINKED IMMUNOABSORBENT ASSAY, RUBELLA

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ELECSYS RUBELLA IGG IMMUNOASSAY; ENZYME LINKED IMMUNOABSORBENT ASSAY, RUBELLA Back to Search Results
Model Number RUBELLA IGG
Device Problem False Negative Result (1225)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 09/14/2020
Event Type  malfunction  
Manufacturer Narrative
This event occurred in (b)(6).Medwatch field phone number was provided as "(b)(6)".
 
Event Description
The initial reporter stated they received a false negative result for one patient sample tested with the elecsys rubella igg immunoassay on a cobas 6000 e 601 module.No incorrect results were reported outside of the laboratory.The sample resulted with a rubella igg value of 7.24 coi (non-reactive) when tested on the e 601 analyzer.The sample was repeated using the diesse elisa rubella igg method, resulting with a value of 42 ui/ml (positive).The serial number of the e 601 analyzer is (b)(4).
 
Manufacturer Narrative
Calibration signals were within expected ranges.Quality controls were within specified ranges.Samples from the patient were provided for investigation and the results obtained by the customer could be reproduced.Investigation of the sample performed with a competitor test determined the complained sample was clearly reactive for rubella igg.The sample did not contain any interfering factors.The patient is regarded as anti-rubella igg low positive.The complained sample is regarded as false negative, however, close to the cut-off of the assay (10 iu/ml).The rubella igg reagent performs within specification.Product labeling states: "a test result < 10 iu/ml does not completely rule out the possibility of an acute rubella infection.Specimens taken very early in the acute phase of infection may not contain any detectable amounts of rubella igg antibodies or may have an antibody concentration < 10 iu/ml." for diagnostic purposes, the results should always be assessed in conjunction with the patient¿s medical history, clinical examination and other finding.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELECSYS RUBELLA IGG IMMUNOASSAY
Type of Device
ENZYME LINKED IMMUNOABSORBENT ASSAY, RUBELLA
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
MDR Report Key10958488
MDR Text Key244328686
Report Number1823260-2020-03110
Device Sequence Number1
Product Code LFX
Combination Product (y/n)N
PMA/PMN Number
K072617
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup
Report Date 01/27/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/28/2021
Device Model NumberRUBELLA IGG
Device Catalogue Number04618793190
Device Lot Number446454
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received 11/13/2020
Initial Date FDA Received12/07/2020
Supplement Dates Manufacturer Received11/13/2020
Supplement Dates FDA Received01/27/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age43 YR
-
-